Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Calimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10606
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Calimmune Inc (Calimmune), a subsidiary of CSL Behring Australia Pty Ltd, is a novel gene therapy program developer. The company’s ex vivio autulogus cell therapy includes CAL-1 and CAL-H. Its CAL-1 offers cell therapies for HIV AIDS. Calimmune’s CAL-H cell therapy provides himoglobinopathies therapies. The company has undisclosed cell therapy to treat hematologic diseases. It has developed a proprietary gene therapy platform called cytegrity. The company’s clinical and laboratory operations are located in Pasadena, California, the US and Sydney, Australia. Calimmune is headquartered in Tucson, Arizona, the US.

Calimmune Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calimmune Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Calimmune Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calimmune Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Calimmune Raises USD15 Million in Series B Financing 10
Licensing Agreements 11
Calimmune Enters into Licensing Agreement with Cincinnati Children’s Hospital Medical Center 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Calimmune Enters into Licensing Agreement with St. Jude Children’s Research Hospital 13
Benitec Enters Into Licensing Agreement With Calimmune For ddRNAi Technology 14
Acquisition 15
CSL Behring Acquires Calimmune 15
Calimmune Inc – Key Competitors 16
Calimmune Inc – Key Employees 17
Calimmune Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Calimmune Inc, Pharmaceuticals & Healthcare, Key Facts 2
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calimmune Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calimmune Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Calimmune Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calimmune Raises USD15 Million in Series B Financing 10
Calimmune Enters into Licensing Agreement with Cincinnati Children’s Hospital Medical Center 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Calimmune Enters into Licensing Agreement with St. Jude Children’s Research Hospital 13
Benitec Enters Into Licensing Agreement With Calimmune For ddRNAi Technology 14
CSL Behring Acquires Calimmune 15
Calimmune Inc, Key Competitors 16
Calimmune Inc, Key Employees 17

List of Figures
Calimmune Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calimmune Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calimmune Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ternium SA:戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Optiscan Imaging Limited (OIL):製品パイプライン分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • A&D Company Ltd (7745):企業の財務・戦略的SWOT分析
    Summary A&D Company Ltd (A&D Company) is a medical equipment company that manufactures, designs, develops, and distributes advanced measuring, controlling, monitoring, and testing instruments. The company’s products include powertrain testing systems, digital analog converter, DSP platform, model ba …
  • Genoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. G …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Matisa Materiel Industriel S.A.
    Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report Summary Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bauhaus International (Holdings) Limited (483):企業の財務・戦略的SWOT分析
    Bauhaus International (Holdings) Limited (483) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • LifeLabs Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeLabsInc (LifeLabs), formerly MDS Diagnostic Services is a laboratory service provider that diagnoses, treats, monitors and prevent diseases in patients. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, …
  • United States Endoscopy Group Inc:企業の戦略的SWOT分析
    United States Endoscopy Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Nishio Rent All Co Ltd (9699):企業の財務・戦略的SWOT分析
    Nishio Rent All Co Ltd (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Schneider National Inc (SNDR):企業の財務・戦略的SWOT分析
    Schneider National Inc (SNDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務情報
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hokkaido Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    Hokkaido Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Hokkaido Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • University of Leeds:医療機器:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 …
  • MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析
    Summary MitoGenetics LLC (MitoGenetics) is a biomedical research and development company which produces proprietary compounds and intellectual property for the treatment of human, animal and plant diseases caused due to mitochondrial dysfunction. The company offers technology to regulate cellular mi …
  • National Research Council of Canada:企業のM&A・事業提携・投資動向
    National Research Council of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Research Council of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆